cu») United States
v2) Patent Application Publication
Murphy et al.
(54) DEVICES, SYSTEMS, AND METHODS FOR
THE FABRICATION OF TISSUE UTILIZING
LINKING
oy NOVO, INC., San Diego, CA
(72) Inveators:Keith Murphy; Los Angeles, CA (US);
Scott Dorfman, San Diego. CA (US)
Richard Jin Law, Newbury Park, CA
(US); Vivian Anne Le, San Diego, CA
(ws)
(93). Assignee: ORGANOVO, INC.,San Diego, CA
ws
QL) Appl. Nos 137794268
(22) Filed: Mar. 14,2013,
Related US. Application Data
Provisional application No, 61/636,442, filed on Apr
20, 2012.
(60
(00 Pub. No: US 2014/0093932 Al
(4s) Pub, Date: ‘Apr. 3, 2014
‘US 20140093932,
Publication Classification
(1) Insel
CRM x00 200601)
CRM 10 (2005.01)
CRN 500 (2006.01),
(2) Us
crc €12M 21/08 (2013.01); C12N S082
(2013.01); C12M 31/00 201301),
usec 4RS/L7RA4; 435/286.3: 435/177
on ABSTRACT
Described herein are bioprinters comprising: one or more
printer beads, wherein a printer head comprises a means for
receiving and bolding atleast one caridge, and wheceia said
cartridge comprises contents selected from one of more of
bio-ink, and support material: a UV Hight module for option:
ally exposing the contents of atleast one cartridge to UV
Tight; a means for calibrating the postion of atleast one
cartridge; and a means for dispensing the contents of at least
‘one cartridge. Also described hi methods of sing-and
bioprinting cartridges for such bioprinters
AGAROSE
BODY
HASMC-HAEC
BODY
HDF
BODYPatent Application Publication Apr. 3, 2014. Sheet 1 of 8 US 2014/0093932 AI
CAPILLARY
+
t
SENSOR THRESHOLD = MAX SENSING DISTANCE
FIG. 1Apr. 3, 2014 Sheet 2 of 8 ‘US 2014/0093932 AL
Patent Application Publication
REFLECTED
UGHT ~
\
LASER SENSOR
FIG. 2Patent Application Publication Apr. 3, 2014 Sheet 3 of 8 US 2014/0093932 AI
FIG. 3Patent Application Publication Apr. 3, 2014 Sheet 4 of 8 US 2014/0093932 AI
AGAROSE HASMC-HAEC HOF
BODY BODY BODY
FIG. 4Patent Application Publication Apr. 3, 2014. Sheet 5 of 8 US 2014/0093932 AI
FIG. 6Patent Application Publication
CAPILLARY ——8
UV CROSSLINKABLE
HYDROGEL,
Apr. 3, 2014 Sheet 6 of 8
US 2014/0093932 AI
365 nm
AAA,
ASDA
5 AVA AV AVA AU
MISSI
M™WDDAALIV
Ja UV LAMPApr. 3, 2014 Sheet 7 of 8 US 2014/0093932 AI
Patent Application Publication
ae
a
816
820
FIG. 8Apr. 3, 2014 Sheet 8 of 8 US 2014/0093932 AI
Patent Application Publication
he | Ma
FIG. 9US 2014/0093932 AI
DEVICES, SYSTEMS, AND METHODS FOR
‘THE FABRICATION OF TISSUE UTILIZING
UV CROSS-LINKING
(CROSS-REPERENCE TO RELATED
"APPLICATIONS,
[0001] This application clims the benefit of US. Appl
tion Ser. No. 61/636, 442 filed Apr 20, 2012, which is hereby
Incomporated by reference in it entirety
BACKGROUND OF INVENTION
[0002] _ A numberof pressing problems confront the health-
‘care indusiry. As of December 2009 there were 105,305
patients registered by United Network for Organ Sharing
(UNOS) as needing an organ tansplant. Between January
and September 2009, only 21,423 transplants were per-
ormed. Fach year more patients are added to the UNOS Tist
than ransplans are performed, resulting in a net increase in
the number of patents waiting for transplant, For example,
atthe beginning of 2008, 75.834 people were reyistered as
needing a kidney; atthe end of that year, the number had
‘grown to 80,972. 16,546 kidney transplants were performed,
that yea, but 33,005 nev patients were added to the list. The
2008 transplant rate for & patient registered by UNOS as
needing & kidney was 20%. The mortality rate of wailist
patients was 7%.
10003) Additionally, the rescarchand development costofa
new pharmaceutical compound sapproximately $1 illion.
See Paul tal (2010). How to improve R&D productivity
the pharmaceutical industry’s grand challenge. Nature
Reviews Drug Discovery 9(3}:203-214. Drag discovery isthe
process by which drugs are discovered and/or designed. The
process of drug discovery generally involvesat less the steps
‘of, identification of candidates, synthesis, characterization,
sereening, and assays for thenpeutie eficacy. Despite
advances in technology and understanding of biological sys.
tems, drug discover is still a longthy, expensive, and inft-
‘cient paces with low rate of new thenspeutie discovery.
SUMMARY OP THE INVENTION
10004) ‘There is » need for tools and techniques that fac
(copplication of regenerative medicine and issue engineer
ing technologies to rlioving the urgent need for tissues and
‘organs. There is also a need for tools and techniques that
substantially increase the number and quality of innovative,
‘costfective new medicines, without incurring ussusain=
able RAD casts. Accordingly the inventors describe herein
devices, systems, axl methods for fabricating tissues and
‘organs.
[0005] -Inone aspect, disclosed herein are bioprinters com
prising: one or more printer heads, wherein a peter head
‘comprises a means for receiving and hokfing atleast one
‘cartridge, and wherein said cartridge comprises contents
selected from one or more of bio-ink and support material: 2
UY light module for opGonaly exposing the conteats of at
Jeast one cartridge to UV light; ands means for dispensing the
‘contents of at least one cartridge. In some embodiments, the
mans for dispensing the contents of atleast one cartridge is
application of a piston, application of pressure, applieation of
‘compressed gas, hydmilies, or a combination thereof. In
some embodiments, the bio-ink oF support material con-
Prises one or more UV cross-linkable materials. In some
ubowiments, the UV light module exposes the conteats ofa
Apr. 3, 2014
least one cartridge to UV Tight prior to dispensing, In some
‘embodiments, the UV light module is tunable with respect
wavelength, intensity, exposure time, or any combinstion
thereof In furher embodiments, the UV light module com-
prises one or more optionally engaged attention filters,
‘wherein the attenuation filters lower UV intensity when
‘engaged, In some embostiments, the bioprintr further com
prises a means for applying a wetting agent to one or more of
printer stage; a receiving surface; a Ueposition orifice; the
bio-ink: the support materials and a. printed constrict
‘wherein the setting agent is applied st one or more time
points selected from: before the bio-ink or suppor material is
isponsed by the bioprinter, substantially concurrently with
‘Gspensing, and aller the biocink or support material is
pense by the bioprinter,
[0006] In another aspect, disclosed herein are methods of
fabricating a tissue consiict comprising the steps of depos
iting bio-ink onto a support, wherein the bio-ink comprises a
LUV eross-linkable material and as boen expose to UV light
{o partially or completely crosslink the UV cross-linkable
‘material to form a semi-solid or solid body; and incubating
the bio-ink to allow it to cohere and to forma tissue, where
sad incubation has a doration of about 1 hour to about
days. Ia some embodiments, the method further comprises
the step of preparing aliquid bio-ink soktion eomprising a
UV cross-linkable material and cells. In further embodi-
‘mens, the method further comprises the step of exposing a
liquid bo-ink solution comprising a UV cross-linkable mate-
ial and cells to UV light to partially or completely cros-link
the UV crosslinkable material to form a semi-solid oF soi
body. In some embodiments, the method furher comprises
the step of depositing bio-ink onto a support, wherein the
bio-ik comprises a UV erost-linkble material ad has not
been exposed to UV light. In some embodiments, the UV
cross-linkable material is @ hydrogel. In some embodiments,
the biosink comprises mammalian cells. In futher embed
reals, the bio-ink comprises differentiated, mammalian
cells. In forther embodiments, the biorink comprises non-
dillerentated, mammalian cells. In some embodiments, the
bio-ink is deposited by extrusion Irom a bioprinter.
[0007] In another aspect, disclosed herein ae bioprinter
‘arteidges, wherein the eontents of the cartridge comprises a
[DV crosslinkable material and optionally eels. In some
embodiments, the UV cross-linkable material is partially or
completely cross-linked. In some embodiments, the UV
‘ros-linkable material is a hydrogel. In some embodiments,
the cartridge comprises a glass-walled reservoir. In some
‘embodiments, the cartridge is permeable to UV light
[0008] In another aspect, disclosed Nerein are UY light
‘modules fora bioprinter comprising a UV light source that
‘optionally exposes the contents of at least one biopriner
cartridge to UV light. In some embodiments, the UV light
‘edule is reversibly atachable to a bioprinter. In some
‘embodiments, the UV light module is tunable with respect t0
‘wavelength, intensity, exposure time, or any combination
thereof. In some embodiments, the UV Tight module furher
comprises one or moreptionally engaged attenuation filters,
Wherein the attenuation filters lower UV intensity when
engaged.
[0009] tn another aspect, diselosed herein ae tissue con-
structs comprising multicellular body on a support sub-
strate, wherein the multicellular body comprises a UV eross-
Tinkable material and cells, where the multicelar body
vas deposited by a bioprnter, provided thatthe muleellularUS 2014/0093932 AI
body was exposed to UV light to partially of con
‘eross-link the UV cross-linkable material to form a semi
solior sold body. In some embuxliments, the construct com-
prises « plurality of multicellular bodies. In some embodi-
ments, the UV cross-linkable material sa hydrogel. In some
‘embodiments, the multicellular body comprises different
‘ated, mammalian cells. In some embodiments, the multicel-
Iular body comprises non-differentinted, mammalian cells
BRIEF DESCRIPTION OF FIGURES
[0010] FIG. 1 illustrates a non-limiting example of calibra-
thon ofa caridgeusinga hernias
[0011] 11G.2sIhsintesa nonlimiting example calibra
Som ofa carpe sing a vertal laser
[0012] FIG. 3ilhnrtes s nonsiniting example of «cape
‘lary pining process.
[0013] FIG. 4 illustrates a non-limiting example of a two-
‘iensional representation ofa bio-prined tase consti
[0014 FIG. Sisters noelimting example ofa three-
lmensional costae genestd by continuous deposition of
PI-T37 ising Novoen MMX™ biopinter connected to
syringe wth 510m aed in his cave, pyramidsbaned
[0015]. FIG. 6ithusttes nonlimiting example ofa tree-
Slimensional costuc generated by continuous deposition of
Pict37 sings Novoen MMX™ bioprnter connected
syringe with a 510 um needle; in this case, cube-shaped (left)
sd hollow cube-sbaped (ight) comnts
[0016] 116.7 iostates a no-limiing schematic ogra
depicting exemplary parameters for exposing a UV cross-
linkable mera fo UV light source inthe context of
Sionsnter
[0017] FIG. 8 illustrates a non-limiting example of a Novo-
Geo MMX"™ bopiterinchatinga UV mode in tinea,
‘printer ead is positioned such tat a capillary abe par
tal incuced toa UV module
[0018] FIG. 9 illustrates a non-limiting example of a Novo-
Gen MMX'™ boprinterincludings UN mod inthiscase,
4 printer head is positioned sch that capillary tbe is
‘alizlyinteduced oa UV module
DETAILED DESCRIPTION OF INVENTION
10019] The invention relates to the fields of regenerative
medicine, tisuelorgan engineering. biologie and medical
research, and drug discovery. More particularly, the invention
relates to devices for fabricating tissues and ongans, systems
and methods for calibrating and using such devices, and ts-
sues and organs fibricated by the devices, systems, and meth-
‘ods disclosed herein
10020] Disclosed herein, in certain embodiments, are bio-
printers comprising: one or more prater heads, wherein &
Printer head comprises a means for receiving and holding st
Teast one carridge, and wherein said cartridge comprises
‘conten selected from one or more of: bio-ink and support
material; a UV light mele for optionally exposing the con-
tents of atleast one cartridge to UV light: and a means for